Usa was Profound Medical’s largest region in fiscal 2025, bringing in $12.25M of $16.10M (76%).
| Geography | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Usa | $5.13M | $7.35M | $12.25M |
| Canada | $230.00K | $2.44M | $3.08M |
| Germany | $1.84M | $891.00K | $773.00K |
| Total | $7.20M | $10.68M | $16.10M |
Profound Medical brought in $16.10M from its three regions in fiscal 2025, the year ended December 31, 2025. That was up 50.7% from $10.68M in fiscal 2024. Usa was the largest at $12.25M (76.1%), ahead of Canada at $3.08M (19.1%) and Germany at $773.00K (4.8%).
Compared with fiscal 2024, Usa grew fastest, up 66.6% to $12.25M, while Germany fell the most, down 13.2% to $773.00K. From fiscal 2023 to 2025, combined revenue from these regions grew from $7.20M to $16.10M, a compound annual growth rate of 49.5%. Usa's share of the total rose from 71.2% to 76.1%.
Recurring - Non-Capital was Profound Medical’s largest product and service line in fiscal 2025, bringing in $9.73M of $16.10M (60%).
| Product and Service | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Recurring - Non-Capital | $6.81M | $8.24M | $9.73M |
| Capital Equipment | $393.00K | $2.44M | $6.37M |
| Total | $7.20M | $10.68M | $16.10M |
Profound Medical brought in $16.10M from its two product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 50.7% from $10.68M in fiscal 2024. Recurring - Non-Capital was the largest at $9.73M (60.4%), ahead of Capital Equipment at $6.37M (39.6%).
Compared with fiscal 2024, Capital Equipment grew 161.0% to $6.37M and Recurring - Non-Capital grew 18.1% to $9.73M. From fiscal 2023 to 2025, combined revenue from these lines grew from $7.20M to $16.10M, a compound annual growth rate of 49.5%. Recurring - Non-Capital's share of the total fell from 94.5% to 60.4%.
Point In Time Revenue was Profound Medical’s largest revenue line in fiscal 2025, bringing in $15.36M of $16.10M (95%).
| Timing of Transfer of Good or Service | FY 2024 | FY 2025 |
|---|---|---|
| Point In Time Revenue | $9.92M | $15.36M |
| Service Revenue Recognized Over Time | $758.00K | $740.00K |
| Total | $10.68M | $16.10M |
Profound Medical brought in $16.10M from its two revenue lines in fiscal 2025, the year ended December 31, 2025. That was up 50.7% from $10.68M in fiscal 2024. Point In Time Revenue was the largest at $15.36M (95.4%), ahead of Service Revenue Recognized Over Time at $740.00K (4.6%).
Compared with fiscal 2024, Point In Time Revenue grew 54.8% to $15.36M, while Service Revenue Recognized Over Time fell 2.4% to $740.00K.
Profound Medical (PROF) reports its revenue by geography, by product and service and by timing of transfer of good or service. In fiscal 2025, Usa was its largest region, bringing in $12.25M (76.1% of the total), followed by Canada at $3.08M (19.1%).
Usa was Profound Medical's largest region in fiscal 2025, bringing in $12.25M, or 76.1% of the $16.10M total across its three regions.
Recurring - Non-Capital was Profound Medical's largest product and service line in fiscal 2025, bringing in $9.73M, or 60.4% of the $16.10M total across its two product and service lines.
Point In Time Revenue was Profound Medical's largest revenue line in fiscal 2025, bringing in $15.36M, or 95.4% of the $16.10M total across its two revenue lines.
Among Profound Medical's regions that make up at least 2% of revenue, Usa grew fastest in fiscal 2025, up 66.6% from $7.35M to $12.25M.
Every figure comes from Profound Medical's annual financial filings, as reported. Each line keeps the name Profound Medical gives it, and years follow its fiscal calendar.
Profound Medical's revenue by geography goes back to fiscal 2023, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.